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CRT-822
Support System of Bioprosthetic Valves With A Heart Shape Commissural Post
Efstathios Andreas Agathos
Athens Medical Center, Filothei-Athens, Greece
BACKGROUND Bioprosthetic valves fail due to torn leaﬂets as a result of increased
forces applied on the commissural posts during the cardiac cycle. To face this problem
a novel Support System (stent) with large openings at the Commissural posts made
from acetal copolymer (POM-C) or Titanium has been developed. The hydrodynamic
performance and durability of bioprosthetic valves constructed using this stent went
under evaluation.
METHODS This stent was initially designed to accommodate aortic and pulmonary
valves derived from marine mammal origin (Phoca Groelandica), showing excellent
hydrodynamic performance when tested in a steady ﬂow system. The same stent was
used to create three trileaﬂet composite porcine valves of 23mm (titanium), 27mm
and 31mm (POM-C) in diameter and one 25mm (titanium) bovine pericardial valve
wrapped around the stent. All valves were tested in a steady ﬂow system. The three
porcine valves underwent fatigue accelerating testing to deﬁne their long term
durability.
RESULTS For the porcine valves the peak pressure was measured as 12.5mmHg,
9.1 mmHg and 7.3mmHg for the 23mm, 27mm and for the 31mm valve respectively.
The 25mm pericardial valve showed a peak pressure of 5.5mmHg. The durability test
showed valve deterioration after 225x106cycles for the 23mm, 265x106 cycles for the
27mm and 240x106 cycles for the 31 mm, values far above the passing standards
according to ISO/DIS 5840.
CONCLUSION This novel stent for bioprosthetic valves offers excellent hydrodynamic
performance for a variety of biological issues tested and above the standards long
term durability, possibly due to the amelioration of forces applied on the commissural
posts during the cardiac cycle.
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Transcatheter Extra-Cardiac Tricuspid Annuloplasty
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William Schenke, Jonathan Mazal, Ozgur Kocaturk, Marcus Chen, Anthony Faranesh,
Robert Lederman
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BACKGROUND We designed and built a device that is positioned along the atrio-
ventricular groove in the pericardial space and tightened to modify the geometry of
the tricuspid annulus to treat functional tricuspid regurgitation. The device is
delivered to the pericardial space from within via trans-atrial puncture.
METHODS 15 swine, including 3 with dilated right heart and functional tricuspid
regurgitation, underwent extra-cardiac tricuspid annuloplasty. The pericardial spaceis accessed with large (12-14Fr) sheaths from a femoral vein, through the right atrium
and by puncture through the right atrial appendage. A self-orienting nitinol
compression device is then deployed around the atrioventricular groove and tight-
ened to exert compressive force to the free-wall of the tricuspid annulus. The atrial
puncture site is closed with an off-the-shelf nitinol closure device.
RESULTS In all 15 animals, trans-atrial pericardial access was uncomplicated and the
device was delivered successfully. Tricuspid septal-lateral and antero-posterior di-
mensions, annular area and perimeter were reduced by 49%, 31%, 59% and 24%
(p<0.001) respectively. Tricuspid leaﬂet coaptation length was increased by 53%
(p<0.001). The degree of annuloplasty correlated closely with the tension delivered
to the device (r2¼0.94, p<0.001). Coronary artery compression was not observed in
any animal, but a bridge-shaped protection element can be positioned over an un-
derlying vessel to deﬂect compressive force. 9 animals were survived for mean
9.7days and tricuspid geometric changes were maintained. In the 3 animals with
functional tricuspid regurgitation, severity of regurgitation by intracardiac echocar-
diography was reduced. Small pericardial effusions were observed immediately post-
procedure but had completely resolved at follow-up. Post-mortem examination
demonstrated ﬁbrotic encasement of the device along the atrioventricular groove and
no tissue erosion. There was no evidence of pericarditis or adhesions between
visceral and parietal pericardial layers.
CONCLUSION This is theﬁrst extra-cardiac structural intervention performed fromwithin
via trans-atrial puncture. The degree of tricuspid annuloplasty achieved is comparable to
current surgical techniques. The trans-atrial pericardial access port is safely closedwith off-
the-shelf devices, with no evidence of cardiac tamponade in swine.
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Transcatheter Aortic Valve Replacement?
Sarkis Kiramijyan, Marco A. Magalhaes, Edward Koifman, Ricardo O. Escarcega,
Nevin C. Baker, Rebecca Torguson, Michael J. Lipinski, Hideaki Ota, Smita I. Negi,
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BACKGROUND Femoral access closure post transcatheter aortic valve replacement
(TAVR) remains challenging. The Perclose ProGlide (PP) device has been utilized in a
dual pre-close strategy; however, failure of this technique occurs in approximately
10% of cases. This study examined the utility of Angio-Seal (AS) in selected cases
where hemostasis is not achieved with the dual PP alone.
METHODS Patients who received a percutaneous transfemoral TAVR with the use of
at least two PP and, given residual bleeding, subsequently received one AS device,
were included. This cohort was divided into two groups: a success group (full ho-
meostasis with two PP and one AS), and a failure group (required additional in-
terventions). The baseline and procedural characteristics, in-hospital VARC-2 major
and minor vascular access site and bleeding complications, change in hemoglobin
of 3 g/dL, and blood transfusions were compared.
RESULTS A total of 169 patients (57% male, mean 83.7 years) underwent femoral
closure with at least two PP followed by one AS. Complete hemostasis was obtained in
140 (83%) cases (Table). In the failure group, there were higher rates of hypertension
(systolic aortic pressure 19228 vs. 12918 mmHg, p¼0.015 and diastolic aortic
pressure 6811 vs. 4215 mmHg, p¼0.050).
CONCLUSIONS The utility of the AS technique when a pre-close PP strategy fails in
patients with difﬁculty in femoral hemostasis after TAVR is feasible. Even when this
strategy fails, hemostasis is achieved with conventional techniques without requiring
surgery.CharacteristicsSuccess Group With
Angio-Seal (n[140)Failure Group With
Angio-Seal (n[29) p-ValueManual compression 0% (0/140) 14% (4/29) p<0.001Additional closure device(s)
prior to Angio-Seal0% (0/140) 7% (2/29) p¼0.020Balloon cross-over technique 15% (20/137) 29% (8/28) p¼0.009
Total access site percutaneous
intervention7% (7/107) 21% (6/28) p¼0.028Access site surgical intervention 3% (3/107) 0% (0/29) p¼1.000
Decrease in hemoglobin of 3 g/dL 8% (9/107) 8% (2/25) p¼1.000
VARC-2 major and minor vascular
complications16% (22/133) 30% (8/27) p¼0.174VARC-2 major and minor bleeding
complications11% (14/132) 15% (4/28) p¼0.220Post-procedural blood transfusion 20% (27/135) 39% (11/28) p¼0.028
